Skip to main content

Advertisement

SpringerLink
Log in

Diabetes Mellitus in Older Patients

Is Tight Blood Glucose Control Warranted?

  • Leading Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Diabetes mellitus is a major health problem in the older population, where it is mainly of the non-insulin-dependent type [i.e. non-insulin-dependent diabetes mellitus (NIDDM)]. Epidemiological evidence and extrapolation of trial data from patients with insulin-dependent diabetes mellitus (IDDM) suggests that improving glycaemic control reduces the risk of developing microvascular complications (i.e. retinopathy, nephropathy and neuropathy) and also slows the rate of progression of these complications in patients with early disease. Macrovascular morbidity and mortality is, however, more common than microvascular disease in the older population and the evidence that improved glycaemic control significantly reduces the impact of macrovascular disease is weak. Thus, the overall benefits of tight glycaemic control are less well defined in older patients, who tend to have NIDDM, than in younger patients with IDDM.

There are small but significant risks associated with tight glycaemic control in the older patient, including potentially fatal hypoglycaemia with sulphonylureas and/or insulin, and fatal metformin-induced lactic acidosis. Patients at especially high risk of these complications can, however, be identified and inappropriate pharmacological intervention can be avoided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86

    Article  Google Scholar 

  2. Reichard P, Nilsson B-Y, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304–9

    Article  PubMed  CAS  Google Scholar 

  3. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes. Lancet 1993; 341: 1306–9

    Article  PubMed  CAS  Google Scholar 

  4. Nathan DM. Inferences and implications: do results from the Diabetes Control and Complications Trial apply in NIDDM? Diabetes Care 1995; 18: 251–7

    PubMed  CAS  Google Scholar 

  5. Klein R. Hyperglycaemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258–68

    Article  PubMed  CAS  Google Scholar 

  6. Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995; 75: 894–903

    Article  Google Scholar 

  7. Lindstrom T, Olsson AG, Von Schenck H, et al. Insulin treatment improves microalbuminuria and other cardiovascular risk factors in patients with type 2 diabetes mellitus. J Intern Med 1994; 235: 253–61

    Article  PubMed  CAS  Google Scholar 

  8. Kuusisto J, Mykkanen L, Pyorala K, et al. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960–7

    Article  PubMed  CAS  Google Scholar 

  9. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS) VIII: study design, progress and performance. Diabetologia 1991; 34: 877–90

    Article  Google Scholar 

  10. Harris MI. Epidemiology of diabetes mellitus among the elderly in the United States. Clin Geriatr Med 1990; 6: 703–19

    PubMed  CAS  Google Scholar 

  11. Wingard DL, Sinsheimer P, Barrett-Connor EL, et al. Community-based study of prevalence of NIDDM in older adults. Diabetes Care 1990; 13 Suppl. 2: 3–8

    Google Scholar 

  12. Dornan T. Diabetes in the elderly: epidemiology. J R Soc Med 1994; 87: 609–12

    PubMed  CAS  Google Scholar 

  13. Department for Economic and Social Information and Policy Analysis, Statistical Division, United Nations Demographic Yearbook. Special issue: population ageing and the situation of elderly persons. New York: United Nations, 1993

    Google Scholar 

  14. Sprafka JM, Pankow J, McGovern PG, et al. Mortality among type 2 diabetic individuals and associated risk factors: the Three City Study. Diabetic Med 1993; 10: 627–32

    Article  PubMed  CAS  Google Scholar 

  15. Knuiman MW, Welborn TA, Whittall DE. An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am J Epidemiol 1992; 135: 638–48

    PubMed  CAS  Google Scholar 

  16. Moss SE, Klein R, Klein BE. Cause-specific mortality in a population-based study of diabetes. Am J Public Health. 1991; 81; 1158–62

    Article  PubMed  CAS  Google Scholar 

  17. Klein R, Klein BEK, Moss SE, et al. The Beaver Dam eye study: retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 1992; 99: 58–62

    PubMed  CAS  Google Scholar 

  18. Moss SE, Klein R, Klein BEK. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994; 101: 1061–70

    PubMed  CAS  Google Scholar 

  19. Naliboff BD, Rosenthal M. Effects of age on complications in adult onset diabetes. J Am Geriatr Soc 1989; 37: 838–42

    PubMed  CAS  Google Scholar 

  20. Klein BEK, Klein R. Ocular problems in older Americans with diabetes. Clin Geriatr Med 1990; 6: 827–37

    PubMed  CAS  Google Scholar 

  21. Cowie CC. Diabetic renal disease: racial and ethnic differences from an epidemiological perspective. Transplant Proc 1993; 25: 2426–30

    PubMed  CAS  Google Scholar 

  22. Lippert J, Ritz E, Schwarzbeck A, et al. The rising tide of end-stage renal failure from diabetic nephropathy type 2: an epidemiological analysis. Nephrol Dial Transplant 1995; 10: 462–7

    PubMed  CAS  Google Scholar 

  23. Disney APS, editor. ANZDATA Report 1994. Adelaide, South Australia: Australia and New Zealand Dialysis and Transplant Registry, 1994

    Google Scholar 

  24. Humphrey LL, Ballard DJ, Frohnert PP, et al. Chronic renal failure in non-insulin-dependent diabetes mellitus: a population-based study in Rochester, Minnesota. Ann Intern Med 1989; 111: 788–96

    PubMed  CAS  Google Scholar 

  25. Nelson RG, Knowler WC, Pettitt DJ, et al. Diabetic kidney disease in Pima Indians. Diabetes Care 1993; 16: 335–41

    Article  PubMed  CAS  Google Scholar 

  26. Ziegler D, Gries FA, Spuler M, et al. The epidemiology of diabetic neuropathy. Diabetic Med 1993; 10 Suppl 2: 82S–6S

    Article  PubMed  Google Scholar 

  27. Cavanagh PR, Derr JA, Ulbrecht JS, et al. Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabetic Med 1992; 9: 469–74

    Article  PubMed  CAS  Google Scholar 

  28. Garcia MJ, McNamara PM, Gordon T, et al. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 1974; 23: 105–11

    PubMed  CAS  Google Scholar 

  29. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16: 434–44

    Article  PubMed  CAS  Google Scholar 

  30. Stegmayr B, Asplund K. Diabetes as a risk factor for stroke: a population perspective. Diabetologia 1995; 38: 1061–8

    Article  PubMed  CAS  Google Scholar 

  31. Humphrey LL, Ballard DJ, Butters MA, et al. The epidemiology of lower extremity amputation in diabetes: a population-based study in Rochester, Minnesota [abstract]. Diabetes 1989; 38 Suppl 2: 33A

    Google Scholar 

  32. Marker JC, Cryer PE, Clutter WE. Attenuated glucose recovery from hypoglycaemia in the elderly. Diabetes 1992; 41: 671–8

    Article  PubMed  CAS  Google Scholar 

  33. Meneilly GS, Cheung E, Tuokko H. Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes 1994; 43: 403–10

    Article  PubMed  CAS  Google Scholar 

  34. Asplund K, Wiholm BE, Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia 1983; 24: 412–7

    Article  PubMed  CAS  Google Scholar 

  35. Sonnenblick M, Shilo S. Glibenclamide induced prolonged hypoglycaemia. Age Ageing 1986; 15: 185–9

    Article  PubMed  CAS  Google Scholar 

  36. Seltzer HS. Drug-induced hypoglycemia: a review of 1,418 cases. Endocrinol Metab Clin North Am 1989; 18: 163–83

    PubMed  CAS  Google Scholar 

  37. Robertson DA, Home PD. Problems and pitfalls of sulphonylurea therapy in older patients. Drugs Aging 1993; 3: 510–24

    Article  PubMed  CAS  Google Scholar 

  38. Tessier D, Dawson K, Tetrault JP, et al. Glibenclamide vs gliclazide in type 2 diabetes of the elderly. Diabetic Med 1994; 11: 974–80

    Article  PubMed  CAS  Google Scholar 

  39. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care 1994; 17: 81–6

    Google Scholar 

  40. White JR, Hartman J, Campbell RK. Drug interactions in diabetic patients: the risk of losing glycémic control. Postgrad Med 1993; 93: 131–9

    PubMed  Google Scholar 

  41. Herings RM, de Boer A, Stricker BH, et al. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet 1995; 345: 1195–8

    Article  PubMed  CAS  Google Scholar 

  42. Dunn CJ, Peters DH. Metformin: a review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 1995; 49: 721–49

    Article  PubMed  CAS  Google Scholar 

  43. Yki-Jarvinen H, Kauppila M, Kujansuu E, et al. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1992; 327: 1426–33

    Article  PubMed  CAS  Google Scholar 

  44. Fassberg J, Toffler WL, Fields SA, et al. Failure of insulin treatment in obese patients with non-insulin-dependent diabetes mellitus. J Fam Pract 1993; 37: 76–81

    PubMed  CAS  Google Scholar 

  45. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2: 154–60

    Article  PubMed  CAS  Google Scholar 

  46. Ducimetiere P, Eschwege E, Papoz L, et al. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980; 19: 205–10

    Article  PubMed  CAS  Google Scholar 

  47. Pyorala K, Savolainen E, Kaukola S, et al. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9½ year follow-up of the Helsinki policemen study population. Acta Med Scand 1985; 701 Suppl.: 38–52

    CAS  Google Scholar 

  48. Stout RW. Insulin and atheroma: 20-yr perspective. Diabetes Care 1990; 13: 631–54

    Article  PubMed  CAS  Google Scholar 

  49. Sturrock NDC, Page SR, Clarke P, et al. Insulin dependent diabetes in nonagenarians. BMJ 1995; 310: 1117–8

    Article  PubMed  CAS  Google Scholar 

  50. Rayfield EJ, Ault MJ, Keusch GT, et al. Infection and diabetes: the case for glucose control. Am J Med 1982; 72: 439–50

    Article  PubMed  CAS  Google Scholar 

  51. Gradman TJ, Laws A, Thompson LW, et al. Verbal learning and/or memory improves with glycémie control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 1993; 41: 1305–12

    PubMed  CAS  Google Scholar 

  52. Jennings PE. The potential of gliclazide, a sulphonylurea, to influence the oxidative processes within the pathogenesis of diabetic vascular disease. Adv Exp Med Biol 1994; 366: 313–24

    Article  PubMed  CAS  Google Scholar 

  53. Ziegler O, Drouin P. Hemobiological properties of gliclazide. J Diabetes Complications 1994; 8: 235–9

    Article  PubMed  CAS  Google Scholar 

  54. Cooper ME, Doyle AE. The management of diabetic proteinuria: which antihypertensive agent? Drugs Aging 1992; 2: 301–9

    Article  PubMed  CAS  Google Scholar 

  55. Ilarde A, Tuck M. Treatment of non-insulin-dependent diabetes mellitus and its complications: a state of the art review. Drugs Aging 1994; 4: 470–91

    Article  PubMed  CAS  Google Scholar 

  56. Scandinavian Simvastatin Survivial Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–9

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Centre, Christchurch Hospital, Private Bag 4710, Christchurch, New Zealand

    Helen Lunt

Authors
  1. Helen Lunt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lunt, H. Diabetes Mellitus in Older Patients. Drugs & Aging 8, 401–407 (1996). https://doi.org/10.2165/00002512-199608060-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199608060-00001

Keywords

Search

Navigation